Literature DB >> 15148653

Epidemiology of rubella infections in Austria: important lessons to be learned.

B Falkensammer1, G Walder, D Busch, A Giessauf, M Dierich, R Würzner.   

Abstract

In order to ascertain the epidemiology of rubella infections in Austria, a seroepidemiological study was performed. Data collected from 115 cases diagnosed at the Institute of Hygiene and Social Medicine of the University of Innsbruck during 2001 were evaluated. The results indicate this infection can no longer be categorised as a paediatric disease (mean age, 18.5 years), and several other findings were particularly striking: (i) 47% of the patients had elevated C-reactive protein levels and 50% had increased anti-streptolysin O titres; (ii) only a few patients complained of fever, while symptoms such as rash and lymphadenopathy, which are also associated with several other viral infections, including HIV, were found frequently; and (iii) the 115 rubella cases detected in the 1-year study period represented an incidence of >13 per 100,000 population. This high incidence of infection underlines the need for further improvement of diagnostic tests and more successful vaccine strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148653     DOI: 10.1007/s10096-004-1138-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   5.103


  10 in total

Review 1.  Acute human immunodeficiency virus type 1 infection.

Authors:  J O Kahn; B D Walker
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

2.  Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Authors:  Frederick M Hecht; Michael P Busch; Bhupat Rawal; Marcy Webb; Eric Rosenberg; Melinda Swanson; Margaret Chesney; Jennifer Anderson; Jay Levy; James O Kahn
Journal:  AIDS       Date:  2002-05-24       Impact factor: 4.177

3.  The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention.

Authors:  Susan E Reef; Teryl K Frey; Katherine Theall; Emily Abernathy; Cindy L Burnett; Joseph Icenogle; Mary Mason McCauley; Melinda Wharton
Journal:  JAMA       Date:  2002 Jan 23-30       Impact factor: 56.272

Review 4.  Rubella virus and arthritis.

Authors:  C A Smith; R E Petty; A J Tingle
Journal:  Rheum Dis Clin North Am       Date:  1987-08       Impact factor: 2.670

5.  Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.

Authors:  L A Mitchell; T Zhang; M Ho; D Décarie; A J Tingle; M Zrein; M Lacroix
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

Authors:  Brent Taylor; Elizabeth Miller; Raghu Lingam; Nick Andrews; Andrea Simmons; Julia Stowe
Journal:  BMJ       Date:  2002-02-16

7.  Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children.

Authors:  Markus Ringler; Georg Göbel; Johannes Möst; Kurt Weithaler
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

8.  Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination.

Authors:  M Zrein; J H Joncas; L Pedneault; L Robillard; R J Dwyer; M Lacroix
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

9.  Comparison of novel synthetic peptide-based DETECT-RUBELLA enzyme immunoassays with Enzygnost and IMx for detection of rubella-specific immunoglobulin G.

Authors:  L Pedneault; M Zrein; L Robillard; F Landry; M Lacroix; J Joncas
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

10.  Thrombocytopenic purpura related to rubella infection.

Authors:  S Ozsoylu; G Kanra; G Savaş
Journal:  Pediatrics       Date:  1978-10       Impact factor: 7.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.